Oral Sulodexide Reduces Albuminuria in Microalbuminuric and Macroalbuminuric Type 1 and Type 2 Diabetic Patients: the Di.N.A.S
J Am Soc Nephrol 13: 1615–1625, 2002 Oral Sulodexide Reduces Albuminuria in Microalbuminuric and Macroalbuminuric Type 1 and Type 2 Diabetic Patients: The Di.N.A.S. Randomized Trial GIOVANNI GAMBARO,* IDA KINALSKA,† ADRIAN OKSA,‡ PETER PONT’UCH,ʈ MILUSE HERTLOVA´ ,§ JINDRICH OLSOVSKY,¶ JACEK MANITIUS,** DOMENICO FEDELE,†† STANISLAW CZEKALSKI,O JINDRISKA PERUSICOVA´ ,‡‡ JAN SKRHA,‡‡ JAN TATON,§§ WLADYSLAW GRZESZCZAK,¶¶ and GAETANO CREPALDIO *Department of Medical and Surgical Science, Division of Nephrology, University of Padua, Padua, Italy; †Department of Endocrinology, Medical Academy, Bialystoc, Poland; ‡Institute of Preventive and Clinical Medicine, Clinical Pharmacology Department, Bratislava, Slovak Republic; ʈFirst Internal Clinic of Medicine, Faculty Hospital, Bratislava, Slovak Republic; §Internal Clinic, Faculty Hospital, Brno, Czech Republic; ¶Second Internal Clinic of Medicine, Diabetology Day-Hospital, Brno, Czech Republic; **Department of Nephrology, The Ludwik Rydygier Medical University in Bydgoszcz, Bydgoszcz, Poland; †† Department of Medical and Surgical Science, Diabetic Center, Geriatric Hospital, University of Padua, Padua, Italy; oDepartment of Nephrology, Medical Academy, Poznan, Poland; ‡‡Third Department of Internal Medicine, Faculty Policlinic, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; §§Chair and Department of Internal Diseases and Diabetology, Medical School, Warsaw, Poland; ¶¶Department and Clinic of Internal Diseases and Diabetology, Silesian School of Medicine, Zabrze, Poland;
[Show full text]